COVID-19 vaccine clinical study in Minnesota

Participate in a COVID-19 vaccine study

We’re proud to announce, with hope and renewed optimism, a big step forward in the fight against COVID-19. HealthPartners Institute has joined Oxford University and AstraZeneca in providing Minnesota’s first Phase 3 COVID-19 vaccine clinical trial.

Thank you for your interest in this COVID-19 vaccine study. The study has reached capacity and we are no longer enrolling new participants.

Vaccine study information and safety

A clinical trial is an important study that helps to answer important questions about an investigational vaccine or medicine, such as how well it works, how safe it is and whether there are side effects. All vaccines must be tested in clinical trials before they can be approved to give to patients.

This study is a Phase 3 trial, which occur toward the end of vaccine development after completing smaller Phase 1 and Phase 2 safety and effectiveness studies. The purpose of this Phase 3 trial is to learn more about an investigational vaccine for the prevention of COVID-19. COVID-19 is caused by the novel coronavirus.

If you are selected to participate, the clinical trial team will explain the possible benefits and risks to you. You can choose not to participate before the trial begins. You can also choose to stop participating at any point during the trial.

We’re proud to help advance this important research, and we’re excited to support study participants during this critical next research step.

Frequently asked questions